In a report released on February 11, Brian Abrahams from RBC Capital maintained a Buy rating on Corbus Pharmaceuticals (CRBP – Research ...

RBC Capital markets adjusted their stance on Cochlear Ltd. (COH:AU) (OTC: CHEOY), a $10.9 billion medical device company ...

After years of lagging behind the retail stars Costco Wholesale and Amazon.com, Walmart is catching up quickly. Its shares rose 72% in 2024, and are up another 16% so far this year. Walmart has become ...

Management provided 2025 adjusted net investment income guidance of $1.97 to $2.14 per share, translating to an 11.5%-12.5% return on equity for net investment income. Easterly emphasized the ...

Capital expenditures for 2025 are projected to range between $60M and $65M, including $30M allocated for two continuous dry kilns. The sale of northern private timberlands is expected to generate an ...

Ward 6 Coun. Sam Trosow called Ford’s comment “absolutely appalling” and took aim at the premier’s “partisan” remarks during ...

Q4 2024 Management View Fortis reported a strong 2024 performance, with $5.2B in capital investments and adjusted EPS growth of 6%. CEO David Hutchens emphasized the company’s regulated growth ...